Zalutumumab Uses, Dosage, Side Effects and more
Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.
| Trade Name | Zalutumumab |
| Generic | Zalutumumab |
| Zalutumumab Other Names | Zalutumumab |
| Type | |
| Formula | C6512H10074N1734O2032S46 |
| Weight | 146641.0546 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
